Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara R Cohen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|September 9, 2020
FDA Label for Over-the-Counter Naloxone. ReplyBarbara R Cohen, Elande Baro, Amanda Pike-McCrudden
The New England Journal of Medicine|May 28, 2020
FDA Initiative for Drug Facts Label for Over-the-Counter NaloxoneBarbara R Cohen, Karen M Mahoney, Elande Baro, et al.
Journal of Primary Care & Community Health|March 25, 2021
The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health EquityChristine Lee, Melanie J McLean, Caroline J Huang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|September 9, 2020
FDA Label for Over-the-Counter Naloxone. ReplyBarbara R Cohen, Elande Baro, Amanda Pike-McCrudden
The New England Journal of Medicine|May 28, 2020
FDA Initiative for Drug Facts Label for Over-the-Counter NaloxoneBarbara R Cohen, Karen M Mahoney, Elande Baro, et al.
Journal of Primary Care & Community Health|March 25, 2021
The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health EquityChristine Lee, Melanie J McLean, Caroline J Huang, et al.
Pageof 1